Your browser doesn't support javascript.
loading
4-Hydroxyphenyl Retinamide Preferentially Targets FLT3 Mutated Acute Myeloid Leukemia via ROS Induction and NF-κB Inhibition.
Zhao, Xin-Ying; Zhang, Ran-Ran; Ye, Qian; Qiu, Fei; Xu, Hao-Yu; Wei, Feng-Gui; Zhang, Hui.
Affiliation
  • Zhao XY; Department of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou, 510623, China.
  • Zhang RR; Guangzhou Women and Children's Medical Center, Institute of Pediatrics, Guangzhou, 510623, China.
  • Ye Q; Department of Pediatrics, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
  • Qiu F; Department of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou, 510623, China.
  • Xu HY; Bioinspired Engineering and Biomechanics Center, Xi'an Jiaotong University, Xi'an, 710049, China.
  • Wei FG; Department of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou, 510623, China.
  • Zhang H; Department of Pediatrics, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Curr Med Sci ; 40(5): 810-816, 2020 Oct.
Article in En | MEDLINE | ID: mdl-33123895

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tretinoin / Leukemia, Myeloid, Acute / Protein Kinase Inhibitors / Fms-Like Tyrosine Kinase 3 Type of study: Prognostic_studies Limits: Humans Language: En Journal: Curr Med Sci Year: 2020 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tretinoin / Leukemia, Myeloid, Acute / Protein Kinase Inhibitors / Fms-Like Tyrosine Kinase 3 Type of study: Prognostic_studies Limits: Humans Language: En Journal: Curr Med Sci Year: 2020 Document type: Article Affiliation country: Country of publication: